Universitätsklinikum Mannheim

Hospital


Location: Mannheim, Germany (DE) DE

ISNI: 0000000121621728

ROR: https://ror.org/05sxbyd35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy (2019) Marme F, Solbach C, Michel L, Fasching P, Schneeweiss A, Blohmer JU, Rezai M, et al. Conference contribution A URINARY METABOLITE CONSTELLATION TO DETECT ACUTE REJECTION IN KIDNEY ALLOGRAFTS (2019) Banas M, Neumann S, Pagel P, Putz FJ, Kraemer BK, Ruemmele P, Eiglsperger J, et al. Journal article CLINICAL AND VIROLOGICAL CHARACTERISTICS AND RETREATMENT OF HCV-INFECTED PATIENTS WITH FAILURE TO MULTIPLE SUBSEQUENT DAA THERAPIES (2019) Dietz J, Vermehren J, Peiffer KH, Wietzke-Braun P, Muellhaupt B, Schattenberg J, Antoni C, et al. Conference contribution Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria (2019) Teumer A, Li Y, Ghasemi S, Prins BP, Wuttke M, Hermle T, Giri A, et al. Journal article Towards structured data quality assessment in the German medical informatics initiative: Initial approach in the MII demonstrator study (2019) Kamdje-Wabo G, Gradinger T, Löbe M, Lodahl R, Seuchter SA, Sax U, Ganslandt T Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution ECP as prognostic Marker for Melanoma (2019) Moreira A, Krueckel A, Schuler G, Utikal J, Heinzerling L Conference contribution Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 (2019) Hofheinz R, Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al. Conference contribution Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution